At first (till the PDF opened up) I thought you were posting the Hebrew link :-).
Do you make anything of antibodies developing in the one patient (if the study were opposite taliglucerase to Cerezyme switching would there be similar risk of antibodies)? I guess more generally I am wondering if the plant based technology has a higher risk of antibodies?
PS Thanks for the Teva's enoxaparin info you posted and enjoy your trip!
Market Data 
Markets 
AI
